TREA

88083918 - SYSDURAQ

Follow

Information

  • Trademark
  • 88083918
  • Serial Number
    88083918
  • Registration Number
    5871305
  • Filing Date
    August 19, 2018
    6 years ago
  • Registration Date
    October 01, 2019
    5 years ago
  • Transaction Date
    October 01, 2024
    3 months ago
  • Status Date
    October 01, 2019
    5 years ago
  • Published for Opposition Date
    July 16, 2019
    5 years ago
  • Location Date
    October 01, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    INGOLD, GERALDINE
  • Attorney Docket Number
    2854-T403US
    Attorney Name
    Frances M. Jagla
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
SYSDURAQ
Case File Statements
  • GS0051: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
  • GS0421: Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Case File Event Statements
  • 8/27/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/28/2018 - 6 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/22/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/30/2018 - 6 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 10/15/2018 - 6 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 10/16/2018 - 6 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 5/31/2019 - 5 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/3/2019 - 5 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/3/2019 - 5 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/4/2018 - 6 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/4/2018 - 6 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/4/2018 - 6 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/10/2019 - 5 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/10/2019 - 5 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/10/2019 - 5 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/10/2019 - 5 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/12/2019 - 5 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/26/2019 - 5 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/16/2019 - 5 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/16/2019 - 5 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/1/2019 - 5 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/24/2024 - 9 months ago
    22 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 6/17/2024 - 7 months ago
    24 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 5/1/2024 - 8 months ago
    23 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 6/17/2024 - 7 months ago
    27 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/17/2024 - 7 months ago
    25 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/17/2024 - 7 months ago
    28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/1/2024 - 3 months ago
    29 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 6/17/2024 - 7 months ago
    26 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP